FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2892099068> ?p ?o ?g. }

• W2892099068 endingPage "678" @default.
• W2892099068 startingPage "670" @default.
• W2892099068 abstract "In this study, we synthesized five N-Boc-L-tyrosine-based analogues to glitazars. The in vitro effects of compounds 1-5 on protein tyrosine phosphatase 1B (PTP-1B), peroxisome proliferator-activated receptor alpha and gamma (PPARα/γ), glucose transporter type-4 (GLUT-4) and fatty acid transport protein-1 (FATP-1) activation are reported in this paper. Compounds 1 and 3 were the most active in the in vitro PTP-1B inhibition assay, showing IC50s of approximately 44 μM. Treatment of adipocytes with compound 1 increased the mRNA expression of PPARγ and GLUT-4 by 8- and 3-fold, respectively. Moreover, both compounds (1 and 3) also increased the relative mRNA expression of PPARα (by 8-fold) and FATP-1 (by 15-fold). Molecular docking studies were performed in order to elucidate the polypharmacological binding mode of the most active compounds on these targets. Finally, a murine model of hyperglycemia was used to evaluate the in vivo effectiveness of compounds 1 and 3. We found that both compounds are orally active using an exploratory dose of 100 mg/kg, decreasing the blood glucose concentration in an oral glucose tolerance test and a non-insulin-dependent diabetes mellitus murine model. In conclusion, we demonstrated that both molecules showed strong in vitro and in vivo effects and can be considered polypharmacological antidiabetic candidates." @default.
• W2892099068 created "2018-09-27" @default.
• W2892099068 creator A5027706141 @default.
• W2892099068 creator A5033728465 @default.
• W2892099068 creator A5037631807 @default.
• W2892099068 creator A5037673215 @default.
• W2892099068 creator A5039489092 @default.
• W2892099068 creator A5042344795 @default.
• W2892099068 creator A5057202385 @default.
• W2892099068 creator A5066646859 @default.
• W2892099068 creator A5070939420 @default.
• W2892099068 creator A5072630267 @default.
• W2892099068 creator A5090807207 @default.
• W2892099068 date "2018-12-01" @default.
• W2892099068 modified "2023-10-18" @default.
• W2892099068 title "Design, synthesis, in vitro, in vivo and in silico pharmacological characterization of antidiabetic N-Boc-l-tyrosine-based compounds" @default.
• W2892099068 cites W1970743385 @default.
• W2892099068 cites W1977041568 @default.
• W2892099068 cites W1983135858 @default.
• W2892099068 cites W1989971569 @default.
• W2892099068 cites W1996484759 @default.
• W2892099068 cites W1998901519 @default.
• W2892099068 cites W2019257417 @default.
• W2892099068 cites W2020465235 @default.
• W2892099068 cites W2030139177 @default.
• W2892099068 cites W2032042237 @default.
• W2892099068 cites W2058819606 @default.
• W2892099068 cites W2061301012 @default.
• W2892099068 cites W2062551263 @default.
• W2892099068 cites W2071447118 @default.
• W2892099068 cites W2084060595 @default.
• W2892099068 cites W2084824909 @default.
• W2892099068 cites W2148019592 @default.
• W2892099068 cites W2164277931 @default.
• W2892099068 cites W2260771076 @default.
• W2892099068 cites W2291178641 @default.
• W2892099068 cites W2480876924 @default.
• W2892099068 cites W2507952488 @default.
• W2892099068 cites W2528606756 @default.
• W2892099068 cites W2598770279 @default.
• W2892099068 cites W2764201092 @default.
• W2892099068 cites W2770219840 @default.
• W2892099068 cites W2783084500 @default.
• W2892099068 cites W2791613077 @default.
• W2892099068 cites W2889388393 @default.
• W2892099068 doi "https://doi.org/10.1016/j.biopha.2018.09.074" @default.
• W2892099068 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30245467" @default.
• W2892099068 hasPublicationYear "2018" @default.
• W2892099068 type Work @default.
• W2892099068 sameAs 2892099068 @default.
• W2892099068 citedByCount "8" @default.
• W2892099068 countsByYear W28920990682019 @default.
• W2892099068 countsByYear W28920990682020 @default.
• W2892099068 countsByYear W28920990682021 @default.
• W2892099068 countsByYear W28920990682022 @default.
• W2892099068 crossrefType "journal-article" @default.
• W2892099068 hasAuthorship W2892099068A5027706141 @default.
• W2892099068 hasAuthorship W2892099068A5033728465 @default.
• W2892099068 hasAuthorship W2892099068A5037631807 @default.
• W2892099068 hasAuthorship W2892099068A5037673215 @default.
• W2892099068 hasAuthorship W2892099068A5039489092 @default.
• W2892099068 hasAuthorship W2892099068A5042344795 @default.
• W2892099068 hasAuthorship W2892099068A5057202385 @default.
• W2892099068 hasAuthorship W2892099068A5066646859 @default.
• W2892099068 hasAuthorship W2892099068A5070939420 @default.
• W2892099068 hasAuthorship W2892099068A5072630267 @default.
• W2892099068 hasAuthorship W2892099068A5090807207 @default.
• W2892099068 hasBestOaLocation W28920990681 @default.
• W2892099068 hasConcept C104317684 @default.
• W2892099068 hasConcept C127078168 @default.
• W2892099068 hasConcept C134018914 @default.
• W2892099068 hasConcept C150903083 @default.
• W2892099068 hasConcept C161573976 @default.
• W2892099068 hasConcept C170493617 @default.
• W2892099068 hasConcept C185592680 @default.
• W2892099068 hasConcept C187345961 @default.
• W2892099068 hasConcept C202751555 @default.
• W2892099068 hasConcept C207001950 @default.
• W2892099068 hasConcept C2775905019 @default.
• W2892099068 hasConcept C2776165026 @default.
• W2892099068 hasConcept C2777866211 @default.
• W2892099068 hasConcept C2779306644 @default.
• W2892099068 hasConcept C55493867 @default.
• W2892099068 hasConcept C85528070 @default.
• W2892099068 hasConcept C86803240 @default.
• W2892099068 hasConcept C98274493 @default.
• W2892099068 hasConceptScore W2892099068C104317684 @default.
• W2892099068 hasConceptScore W2892099068C127078168 @default.
• W2892099068 hasConceptScore W2892099068C134018914 @default.
• W2892099068 hasConceptScore W2892099068C150903083 @default.
• W2892099068 hasConceptScore W2892099068C161573976 @default.
• W2892099068 hasConceptScore W2892099068C170493617 @default.
• W2892099068 hasConceptScore W2892099068C185592680 @default.
• W2892099068 hasConceptScore W2892099068C187345961 @default.
• W2892099068 hasConceptScore W2892099068C202751555 @default.
• W2892099068 hasConceptScore W2892099068C207001950 @default.
• W2892099068 hasConceptScore W2892099068C2775905019 @default.
• W2892099068 hasConceptScore W2892099068C2776165026 @default.

• next